Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Shandong Xinhua Pharmaceutical Company Limited has announced that a board meeting will be convened on October 29, 2024, to review the company’s unaudited financial results for the nine months ending September 30, 2024. Additionally, the meeting will address any other business matters that may arise. This announcement was made public by Chairman He Tongqing on October 14, 2024.
For further insights into HK:0719 stock, check out TipRanks’ Stock Analysis page.